Details of the Drug

General Information of Drug (ID: DM9IG2P)

• Drug Name: Cantide + Cisplatin
• Synonyms: cis-Diaminedichloroplatinum; CPDC; cis-Diamminedichlorplatine; cis-Dichlorodiamine platinum; Diamminedichloroplatinum; Platinum diamine dichloride; Platinum, diamminedichloro-; trans-Diaminedichloroplatinum; NCGC00090759-01; DSSTox_CID_4983; DSSTox_RID_77611; DSSTox_GSID_24983; CAS-15663-27-1; Platiblastin; cisplatin complex; DDPt; cis-Platinum(II); Pt(II) Complex; cis Pt II; CPDD; dichloroplatinumdiamine; Platinum(IV) Complex; Platinum (II) complex; Neuro_000055; cis-Platinum diamminedichloride; DTXSID4024983; MolPort-003-983-464

Indication

Disease Entry	ICD 11	Status	REF
Tumour	2A00-2F9Z	Investigative	[1]

• Therapeutic Class: Antisense
• Drug Type: Combination drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight; 298.03
  Logarithm of the Partition Coefficient; Not Available
  Rotatable Bond Count; 0
  Hydrogen Bond Donor Count; 2
  Hydrogen Bond Acceptor Count; 2
• Chemical Identifiers:
  Formula: Cl2H4N2Pt
  IUPAC Name: azanide;dichloroplatinum(2+)
  Canonical SMILES: [NH2-].[NH2-].Cl[Pt+2]Cl
  InChI: InChI=1S/2ClH.2H2N.Pt/h2*1H;2*1H2;/q;;2*-1;+4/p-2
  InChIKey: DQLATGHUWYMOKM-UHFFFAOYSA-L
• Cross-matching ID:
  PubChem CID: 2767
  CAS Number: 26035-31-4
  DrugBank ID: DB00515
  TTD ID: D08ZRW

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
TERT messenger RNA (TERT mRNA)	TTQY2EJ	TERT_HUMAN	Not Available	[1]

References

• [1] Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.